Background: Stretch marks are common permanent dermal lesions that can cause psychosocial distress. A number of treatment modalities are available, with the majority targeted towards collagen production. Objectives: To develop and field test a new BODY-Q scale to measure appearance of stretch marks in order to provide a means to incorporate the patient perspective into future treatment studies. Methods: We previously described the development of the BODY-Q conceptual framework, which involved a literature review, 63 patient interviews, 22 cognitive interviews and input from 9 experts, and the international field-test study that involved 403 weight loss and 331 body contouring patients. To develop the Stretch Marks scale, we reexamined appearance codes from the original interviews. The scale was field tested in an international study. Rasch measurement theory (RMT) analysis was used to refine the scale and examine measurement properties. Results: The Stretch Marks scale was completed by 630 participants, who provided 774 assessments. After dropping 3 items, the data fit the Rasch model (P = 0.56). Items (eg, length, width, amount, location, up close) mapped out a well-targeted clinical hierarchy. All items had ordered thresholds and good item fit. There was no evidence of differential item functioning (bias) by gender, age group or language (English vs Danish). The scale evidenced high reliability (ie, person separation index = 0.94, Cronbach's alpha = 0.97). For construct validity, the mean score correlated with the total number of body areas with stretch marks, higher BMI before bariatric surgery, and other BODY-Q scales. Conclusions: This scale could be used to measure the impact of innovative treatments for stretch marks.
Since 1980 obesity has more than doubled worldwide. In 2014, 39% of adults were overweight and 13% were obese. 1 Besides severe health conditions, such as cardiovascular diseases and diabetes, obesity is also known to be associated with stretch marks and other skin conditions. 2 Bariatric surgery has been shown to be the most effective treatment of moderate to severe obesity, 3, 4 however research has shown that the skin tissue still suffers from significant signs of damage after bariatric surgery. 5 Stretch marks are common permanent dermal lesions that can be associated with psychosocial distress and thereby affect quality of life. 6, 7 A number of treatment modalities are available, with the majority targeted towards increasing collagen production. No clearly efficient treatment for stretch marks has been identified. 6, 8 In a previous review on treatment modalities, Al-Himdani et al describe the use of different outcome assessment tools, including subjective visual scoring and various imaging modalities. 9 In addition, a recent review of therapeutic targets in the management of stretch marks by Hague et al, concluded that an important limitation in the field involved the outcome measures used. The authors describe that many studies included patient assessment and satisfaction scores, but that none of the studies used a validated instrument. 6 To measure outcomes such as health-related quality of life (HR-QOL) and satisfaction with appearance, the gold standard approach is to use a rigorously developed patient-reported outcome (PRO) instrument. 10 In order to measure outcomes for treatment of stretch marks, a PRO instrument specifically developed for this purpose is needed. [11] [12] [13] [14] [15] The aim of this study is to describe the development and psychometric validation of a new BODY-Q scale to measure appearance of stretch marks, which can be used to incorporate the patient perspective into future treatment studies. This new scale adds to the BODY-Q, which was previously developed by our research team. 16 
METHODS
In Canada, research ethics approval was obtained at McMaster University (Hamilton Integrated Research Ethics Board) and the University of British Columbia (Behavioural Research Ethics Board). In the United States, ethics approval was obtained through the IRB Company Incorporated (Buena Park, Calif.). Ethics approval was also obtained from the National Health Service in the United Kingdom. In Denmark, the study was reported to the Danish Data Protection Agency.
Qualitative Phase
We previously described the development of the BODY-Q conceptual framework, which adhered to recommended methods for PRO instrument development [11] [12] [13] [14] [15] and followed our team`s mixed methods approach described in detail elsewhere. 17 A literature review, 18 63 patient interviews, 22 cognitive patient interviews, and input from 9 experts were used to design 19 BODY-Q scales/checklist that measure appearance (of the body, upper arms, abdomen, back, buttocks, inner thighs, hips and outer thighs, skin, and body contouring scars), health-related quality of life (body image, physical, psychological, sexual, social and obesity-specific symptoms), and healthcare experience (information, doctor, medical team, and office staff). The BODY-Q was field tested between November 2013 and February 2015 in weight loss and body contouring patients from Canada, the United States, and the United Kingdom. We subsequently developed a 13-item scale to measure appearance of stretch marks. Content for the BODY-Q Stretch Marks scale was developed by reexamined general and specific appearance codes from the original set of 63 patient interview transcripts. This scale asks respondents to indicate how bothered they are by the appearance of their stretch marks in terms of characteristics, such as their length, width, location, noticeability, etc.
Quantitative Phase
Overall, the data collection took place in three rounds from October 2014 to November 2016. First, the BODY-Q field-test study took place between November 2013 and February 2015. Methods for this study are described in detail elsewhere. 16 The Stretch Marks scale was added to the ongoing BODY-Q field test in October 2014 and continued until February 2015. Participants in the field test who were asked to complete the Stretch Marks scale were recruited from a bariatric surgery program in Canada (St Joseph's Healthcare Bariatric Program, Hamilton), cosmetic surgery clinics providing body contouring in Vancouver, Canada and Atlanta, United States, and a weight loss program in Aberdeen, Scotland. Data were collected using an iPad directly into a secure web-based application (Research Electronic Data Capture (REDCap), or a questionnaire booklet. Branching logic and/or instructions was used to ensure that only participants with stretch marks completed the Stretch Marks scale.
Second, the Stretch Marks scale was also included in a follow-up study of the weight loss patients recruited into the BODY-Q field test from St Joseph's Healthcare Bariatric Program, Hamilton. 19 The follow-up study began in June 2016 and ended November 2016. Patients without an email address, and patients whose email address was no longer valid (message returned) were contacted by phone. Patients, for whom an email or phone number was not available, and anyone we could not reach by email or phone, were sent the BODY-Q in the mail. Up to 2 e-mailed reminders, spaced by 1 week, and/or 2 postal reminders spaced by 3 weeks, were sent to nonrespondents. Patients received up to 2 phone call reminders as necessary.
Third, translations of the BODY-Q Stretch Marks scale into Danish followed international guidelines as described in detail elsewhere. 20, 21 In Denmark, participants were recruited between June 2015 and June 2016 from 4 different departments from the Region of Southern Denmark: Departments of Endocrinology at Hospital of Southwest Jutland and Odense University Hospital, and Departments of Plastic Surgery at Hospital of Southwest Jutland and Odense University Hospital. Participants could be at any point in their weight loss journey (ie, pre-/postbariatric surgery or pre-/postbody contouring). Data were collected using a REDCap survey at home or in the outpatient clinic using an iPad prior to their scheduled appointment. 10, 20, 21 
Analysis
The statistical analysis of the descriptive data was performed using SPSS software (IBM SPSS Statistics, version 24.0, IBM Corp). The psychometric analysis was carried out with Rasch measurement theory (RMT) 22 using RUMM 2030 software (RUMM version 2030, RUMM Lab.). Decisions on which items to keep were based on statistical and graphical tests explained below and in more detail elsewhere. 23, 24 For the tests of item fit, the sample was amended to 500. 24 The following psychometric tests were performed:
Thresholds for Item Response Options: Thresholds between response options (eg, A little bothered and
Not at all bothered were investigated to evaluate if they were ordered as intended in accordance with the Rasch model (for example, that a "2" on a 4-point scale would sit lower in the continuum than a "3" etc.).
Item Fit Statistics: To examine if scale items worked
together as a set to map out a clinical hierarchy, three fit indicators were examined: item characteristic curves; log residuals (item-person interaction) and chi-square values (item-trait interaction). Fit statistics were interpreted together and in accordance to clinical relevance of each item. 3. Dependency: Residual correlations between pairs of items were examined to evaluate if any of the items directly influenced the responses to other items. 25 4 . Targeting: To determine if items were spread evenly over a reasonable range, person and item locations were examined in order to evaluate whether the set of items matched the range of the construct as experienced by the sample. 5. Stability: To determine if items in a scale worked the same across subgroups within the sample, differential item functioning (DIF) was explored. We investigated DIF by age-group (18-39, 40-49, ≥50 years) and language (English, Danish). For each of these person factors, we used the random sample feature within Rumm2030 software to choose a random sample. The random sample subset size was set to that of the smallest subgroup within each of the person factors (eg, for language we chose a random sample from the larger Danish sample to match the English sample). Significant chi-square values (after Bonferroni adjustment for multiple comparisons) were used to indicate items with potential DIF. 26 Higher values were associated with greater reliability.
Rasch logit scores for the Stretch Marks scale were transformed into scores from 0 (worse) to 100 (best). The proportion of participants who scored at the floor and ceiling of the scales were examined. Participants were asked to self-report the amount of stretch marks they had (a little, a moderate amount, or a lot) and where the stretch marks were (abdomen, breasts/ chest, back, inner thighs, hips and/or outer thighs, upper arms, buttocks, and other). We computed a total score (range 1 to 8) for the total number of areas of their body with stretch marks. For construct validity we tested a number of hypotheses. In terms of stretch marks on the body, we hypothesized that the mean score on the Stretch Marks scale would be incrementally lower on an ANOVA based on the overall amount of stretch marks reported (ie, a little, a moderate amount, a lot). We also hypothesized that lower scores on the Stretch Marks scale would correlate with the reporting of a higher number of areas of the body with stretch marks. In terms of weight loss, we hypothesized that lower scores on the Stretch Marks scale would correlate with higher values for reported BMI before bariatric surgery. Finally, we hypothesized that lower scores for the Stretch Marks scale would correlate with lower scores on all of the other BODY-Q scales measuring appearance (of the body, upper arms, abdomen, back, buttocks, inner thighs, hips and outer thighs, and skin) and health-related quality of life (body image, physical, psychological, sexual, social). These scales were previously shown to have strong psychometric properties. 16 We examined homogeneity of variance and normality assumptions prior to conducting the analyses. Since data for BODY-Q scales for subgroups were found to be normally distributed, parametric statistics were used to examine correlations and mean differences. P values < 0.05 were considered statistical significant.
RESULTS
The Stretch Marks scale was completed by 630 participants, who provided a total of 774 assessments. The sample included 44 participants from the original BODY-Q field-test study (14 from the United Ststes site, 4 from Vancouver, and 26 from Scotland), 195 from the BODY-Q bariatric follow-up study of the Hamilton sample, and 391 patients from Denmark. The response rate based on the sites that incorporated the Stretch Marks scale for the original BODY-Q study and follow-up study was 80%. For the original Danish sample the response rate was 76%, however the Danish sample were only given the Stretch Marks scale if they reported to have stretch marks. Out of the original Danish sample 91% reported to have stretch marks and 100% of those filled out the Stretch Marks scale. Table 1 shows sample characteristics. The sample included more females (n = 522, 82.9%). At time of assessment mean age was 44.3 (SD = 10; range, 18-71 years), and BMI was 32.1 kg/m 2 (SD = 8; range, 20-68 kg/m 2 ). The data included 99 prebariatric surgery assessments, 342 postbariatric assessments, 148 prebody contouring assessments, and 185 postbody contouring assessments.
Overall, the RMT analysis provided evidence of reliability and validity of the new Stretch Marks scale. Table 2 provides an overview of RMT statistics. The analysis resulted in the refinement of a 10-item Stretch Marks scale. Three items were excluded because of poor item fit. All of the 10 remaining items had ordered thresholds. ure shows that response options were ordered and that the items mapped out a clinical hierarchy that ranged from the item "Not being able to wear certain clothes because of your stretch marks," which the sample was the least bothered about, to "How your stretch marks look up close?" which was the item that the sample was most bothered about.
The data fit the Rasch model (chi-square = 87.2; df = 90; P = 0.56). The scale evidenced high reliability, with the PSI = 0.94 (with extremes) and 0.93 (without extremes). The Cronbach alpha value was 0.97. Item fit was outside the criteria of −2.5 to +2.5 for 4/10 items, but all items had nonsignificant chi-square values. Item residual correlations were above 0.30 for 4 pairs of items (range 0.35 to 0.50). Analysis performed that grouped items 1, 2, 3 into a subtest and items 9 and 10 into a second subtest dropped the PSI to 0.912 (with) and 0.91 (without) extremes. With a difference in PSI value ≤0.03 the correlated items were found to have marginal influence on scale reliability. Figure 2 illustrates the person-item threshold distribution according to the phase of weight loss journey, as well as by the amount of reported stretch marks. As the majority of the sample fits within the scope of the scales measurement, the findings provided evidence that the scale was targeted to the sample, though with some participants at the floor and ceiling.
DIF was examined by language, age group, and gender. We observed no evidence of DIF for any item on any of the 3 sample characteristics.
For construct validity, all 4 hypotheses were fully or partially supported. First, the mean score of stretch marks varied significantly by reported amount of stretch marks (P = 0.026 on ANOVA). While the highest (best) scores where in those with the fewest amount of stretch marks (54.1, SD = 29.5), the mean scores for those with a moderate amount (59.5, SD = 5.4) and a lot (59.5, SD = 31.6) did not differ incrementally. Second, a greater number of areas of the body with stretch marks was negatively correlated with the Stretch Marks scale score (−0.40, P < 0.001, N = 771). Figure 3 shows the mean score on the Stretch Marks scale by number of areas with stretch marks, which ranged from mean score 71.0 (SD = 26.1) for 1 area to mean score 32.4 (SD = 23.2) for 7 areas. Third, higher BMI before bariatric surgery was negatively correlated with the Stretch Marks scale score (−0.13, P < 0.001, N = 745). Finally, lower scores for the Stretch Marks scale correlated significantly with lower scores on all other BODY-Q scales (P < 0.001 for all scales) ( Table 3) .
DISCUSSION
Stretch marks are a common concern among weight loss patients. With increasing focus on patient centered care, PRO instruments have become a crucial tool in the evaluation of outcomes. Rigorously developed PRO instruments are also increasingly being incorporated into clinical trials. 27 With stretch marks, Hague et al have shown that PRO instruments are lacking in treatment studies. From 92 articles reviewed, a wide range of mainly ad hoc measures of patient satisfaction was used. Most studies that used a patient evaluation of outcome, included simple patient evaluation scores (eg, worsened, no change, improved). 28 Other scoring systems included scales, such as the Global Aesthetic Improvement Scale, 29 which are not specifically developed for evaluation of stretch marks. Hague et al concluded that none of the scoring systems reviewed were validated, and called for a standardized outcome measure for use in treatment studies. 6 As treatments for stretch marks continue to evolve, a carefully developed, valid, reliable PRO instrument that accurately measures clinical change is needed To provide meaningful measurement, PRO instruments are needed that ask the right questions about outcomes that matter to patients for a specific context of use. 30 PRO instruments are especially helpful in conditions where concepts of interest to patients are highly subjective, such as appearance. Our field-test study of the BODY-Q Stretch Marks scale provided evidence that this new scale was valid and reliable and well targeted to measuring patients' experience of being bothered by how their stretch marks look. Furthermore, our study confirms, that this new Stretch Mark scale worked the same across age, gender, and language. Future psychometric research is needed to measure other measurement properties, including test retest reliability and responsiveness to clinical change following treatment for stretch marks. The Stretch Marks scale provides a new PRO instrument for use in both research and clinical practice, and has the potential to play a central role in future treatment studies according to measuring change from the patient perspective in a valid and reliable way.
Our study has several limitations. First, our sample included more women than men, though this reflects the demographic of patients seeking bariatric and body contouring patients. 31 Second, most of our sample was cross-sectional, which limited our ability to examine the Stretch Marks scale's ability to measure change. Third, data collection for this study was restricted to self-report. We found no difference in mean score among participants who reported a moderate amount vs a lot of stretch marks, which highlights the limitations of a single item self-report question to quantify amount of stretchmark. Finally, our sample was largely a weight loss sample that included participants who had bariatric surgery or postweight loss body contouring. Further research is needed to evaluate the Stretch Marks scale in patients whose stretch marks are caused by pregnancy, puberty, and other medical conditions and/or treatments that induce stretch marks.
CONCLUSION
The BODY-Q Stretch Marks scale evidenced validity and reliability in a large sample of people with stretch marks. This new scale can be used to collect appearance-specific outcomes data from the patient perspective. The Stretch Marks scale has the potential to improve future research in the area of stretch mark treatment. 
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